Cambridge Investment Research Advisors’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.72M Buy
42,754
+9,009
+27% +$337K ﹤0.01% 1716
2025
Q4
$1.17M Buy
33,745
+18,802
+126% +$1.48M ﹤0.01% 1974
2025
Q3
$1.24M Buy
14,943
+4,671
+45% +$338K ﹤0.01% 1883
2025
Q2
$754K Sell
10,272
-1,733
-14% -$126K ﹤0.01% 2175
2025
Q1
$1.37M Sell
12,005
-7,761
-39% -$472K ﹤0.01% 1620
2024
Q4
$996K Sell
19,766
-7,089
-26% -$371K ﹤0.01% 1878
2024
Q3
$1.24M Sell
26,855
-259,395
-91% -$9.22M ﹤0.01% 1705
2024
Q2
$9.3M Sell
286,250
-38,021
-12% -$1.04M 0.03% 497
2024
Q1
$8.17M Buy
324,271
+313,543
+2,923% +$7.41M 0.03% 531
2023
Q4
$348K Sell
10,728
-162,724
-94% -$4.47M ﹤0.01% 2485
2023
Q3
$4.73M Buy
+173,452
New +$5.02M 0.02% 680
2023
Q2
Sell
-366,220
Closed -$7.93M 3193
2023
Q1
$7.93M Buy
+366,220
New +$8.03M 0.04% 440

Other funds holding CORT